Table 1.

Patients and treatment characteristics

Patient number	1	2	3/3a	4	5
Sex (male/female)	m	m	f	f	m
Age (years)	56	36	49	61	67
Primary disease	Autoimmune hepatitis	Cystic fibrosis	Autoimmune hepatitis	Granulomatous liver disease	M. Werlhof with liver cirrhosis
Single/total dose	0.5/3.0 Gy	0.5/3.0 Gy	0.5/3.0 Gy Second course (3a): 0.5/3.0 Gy	0.5/3.0 Gy	0.5/3.0 Gy
Follow-up (months)	21	35	24 (36) and (3a) 12	7	2